Home > Insider Trading > Onyx Pharmaceuticals Inc

Onyx Pharmaceuticals Inc (ONXX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) - Biotech Buyouts: Who's Next?

There's been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (NASDAQ:AMGN). After initially rebuffing Amgen, Inc.

Keep Reading →

August 23rd, 2013 - News

Onyx Pharmaceuticals, Inc. (ONXX), Johnson & Johnson (JNJ): Celgene Corporation (CELG)'s Multiple Myeloma Powerhouse

Earlier this month, biotech powerhouse Celgene Corporation (NASDAQ:CELG) announced that the European Commission approved the combinational therapy of pomalidomide, known in the United States as Pomalyst...

Keep Reading →

August 22nd, 2013 - News

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech's Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)'s Huge Week

Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts.

Keep Reading →

August 19th, 2013 - News

Incyte Corporation (INCY), BioMarin Pharmaceutical Inc. (BMRN): Two Biotech Stocks That Could Be on Novartis AG (ADR) (NVS)'s Buyout Radar

The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.

Keep Reading →

August 16th, 2013 - News

Celgene Corporation (CELG), Compugen Ltd. (USA) (CGEN): This Week in Biotech

With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

August 12th, 2013 - News

Amgen, Inc. (AMGN), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): A Closer Look at the Battle Over Cancer Treatments

Over the past year, the battle over cancer treatments has heated up considerably. Big pharma companies such as Amgen, Inc. (NASDAQ:AMGN), Pfizer Inc. (NYSE:PFE) and Merck & Co., Inc.

Keep Reading →

August 7th, 2013 - News

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July. But can a deal give the stock another boost? I’m doubtful.

Keep Reading →

August 6th, 2013 - News

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): This Orphan Drug Company Only Appears Expensive

In the last couple of months, we saw two big offers being made - and rejected - in the biotech sector. Both times, the companies that rejected these offers saw huge spikes in their respective stocks.

Keep Reading →

August 5th, 2013 - News